The novel epithelial-mesenchymal transition-related proteins and their therapeutic targets in cholangiocarcinoma: a narrative review
- PMID: 37435208
- PMCID: PMC10331758
- DOI: 10.21037/jgo-22-1126
The novel epithelial-mesenchymal transition-related proteins and their therapeutic targets in cholangiocarcinoma: a narrative review
Abstract
Background and objective: Cholangiocarcinoma (CCA), a liver cancer of bile duct epithelial cells, is a severe health issue in northeastern Thailand. The epithelial-mesenchymal transition (EMT) is a crucial process in the development of CCA. To comprehend oncogenic EMT in CCA, several newly found EMT factors are being explored in these underlying pathways. This narrative review explained the latest in vitro and in vivo findings on the molecular mechanisms of 21 new EMT-related proteins that affect CCA progression.
Methods: We evaluated the PubMed database for relevant articles that fulfilled our criteria for investigating the molecular pathways of the novel EMT markers involved in oncogenic EMT and how they contribute to CCA development, including cell proliferation, apoptosis, invasion, migration, and chemoresistance.
Key content and findings: We discuss the potential of these new EMT markers as diagnostic, prognostic, and therapeutic indicators for CCA and describe their underlying mechanisms in the development of the disease. The discovery of several oncogenic EMT proteins and their key signaling pathways and downstream targets will also broaden novel paths of investigation into the diagnosis and targeted treatment of CCA.
Conclusions: The EMT-related proteins that were found are good sources of knowledge and interesting information for future research. The possible ways to treat CCA that could be tested in clinical trials were also discussed.
Keywords: Cholangiocarcinoma (CCA); biomarkers; epithelial-mesenchymal transition (EMT).
2023 Journal of Gastrointestinal Oncology. All rights reserved.
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://jgo.amegroups.com/article/view/10.21037/jgo-22-1126/coif). The authors have no conflicts of interest to declare.
Similar articles
-
14-3-3ζ and aPKC-ι synergistically facilitate epithelial-mesenchymal transition of cholangiocarcinoma via GSK-3β/Snail signaling pathway.Oncotarget. 2016 Aug 23;7(34):55191-55210. doi: 10.18632/oncotarget.10483. Oncotarget. 2016. PMID: 27409422 Free PMC article.
-
EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.J Hepatol. 2014 Aug;61(2):325-32. doi: 10.1016/j.jhep.2014.03.033. Epub 2014 Apr 3. J Hepatol. 2014. PMID: 24704591
-
Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.Pathol Res Pract. 2020 Jan;216(1):152733. doi: 10.1016/j.prp.2019.152733. Epub 2019 Nov 11. Pathol Res Pract. 2020. PMID: 31812439
-
Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.Int J Mol Sci. 2019 Aug 25;20(17):4154. doi: 10.3390/ijms20174154. Int J Mol Sci. 2019. PMID: 31450710 Free PMC article. Review.
-
Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks.J Hepatol. 2017 Feb;66(2):424-441. doi: 10.1016/j.jhep.2016.09.010. Epub 2016 Sep 26. J Hepatol. 2017. PMID: 27686679 Review.
Cited by
-
Blurring the Anatomical Lines in Extrahepatic Cholangiocarcinoma: An Integrated Clinic-Oncological and Exploratory Proteomic Comparison of Perihilar and Distal Tumors.Ann Surg Oncol. 2025 Jul 16. doi: 10.1245/s10434-025-17811-x. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40670839
References
Publication types
LinkOut - more resources
Full Text Sources